The use of atypical antipsychotics beyond psychoses

Efficacy of quetiapine in bipolar disorder

Emanuela Mundo, Elisabetta Cattaneo, Silvia Zanoni, A. Carlo Altamura

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background and rationale: Atypical antipsychotics have been successfully used in the treatment of bipolar disorder (BD), either as adjunctive or as monotherapy. Quetiapine is an atypical antipsychotic extensively used in the treatment of psychotic disorders. It has serotonergic and dopaminergic activity and it appears to be selective for the mesolimbic and mesocortical dopamine system. The aim of this paper was to review the recent literature on the use of quetiapine in the treatment of BD. Methods: The literature databases currently available online were searched for papers on quetiapine and BD. Papers and reports published between January 1995 and June 2005 were selected and reviewed critically. Results: Augmentative low dose quetiapine was found to be effective in BD partially responsive to conventional mood-stabilizers. Manic and mixed episodes have been the best studied, and quetiapine was found to be effective either as monotherapy or as adjunctive therapy in both randomized clinical trials and open-label studies. Data on the use of quetiapine in bipolar depression showed a significant efficacy and high remission rates. Maintenance data suggested a role of quetiapine as a good alternative to classical mood stabilizers in reducing recurrence rates of BD. A few studies on the efficacy in rapid cycling BD have also been published. Conclusions: Quetiapine is an effective agent for the short- and long-term treatment of BD. The mechanism of action of quetiapine as a mood stabilizer is still unknown. Some preliminary data suggest the involvement of glutamate pathways but further studies are needed to clarify this issue.

Original languageEnglish
Pages (from-to)139-148
Number of pages10
JournalNeuropsychiatric Disease and Treatment
Volume2
Issue number2
DOIs
Publication statusPublished - 2006

Fingerprint

Bipolar Disorder
Psychotic Disorders
Antipsychotic Agents
Quetiapine Fumarate
Glutamic Acid
Dopamine
Randomized Controlled Trials
Maintenance
Databases
Recurrence

Keywords

  • Atypical antipsychotics
  • Bipolar disorder
  • Quetiapine
  • Treatment

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

The use of atypical antipsychotics beyond psychoses : Efficacy of quetiapine in bipolar disorder. / Mundo, Emanuela; Cattaneo, Elisabetta; Zanoni, Silvia; Altamura, A. Carlo.

In: Neuropsychiatric Disease and Treatment, Vol. 2, No. 2, 2006, p. 139-148.

Research output: Contribution to journalArticle

@article{154499325abd4e9592aa3a1000390e12,
title = "The use of atypical antipsychotics beyond psychoses: Efficacy of quetiapine in bipolar disorder",
abstract = "Background and rationale: Atypical antipsychotics have been successfully used in the treatment of bipolar disorder (BD), either as adjunctive or as monotherapy. Quetiapine is an atypical antipsychotic extensively used in the treatment of psychotic disorders. It has serotonergic and dopaminergic activity and it appears to be selective for the mesolimbic and mesocortical dopamine system. The aim of this paper was to review the recent literature on the use of quetiapine in the treatment of BD. Methods: The literature databases currently available online were searched for papers on quetiapine and BD. Papers and reports published between January 1995 and June 2005 were selected and reviewed critically. Results: Augmentative low dose quetiapine was found to be effective in BD partially responsive to conventional mood-stabilizers. Manic and mixed episodes have been the best studied, and quetiapine was found to be effective either as monotherapy or as adjunctive therapy in both randomized clinical trials and open-label studies. Data on the use of quetiapine in bipolar depression showed a significant efficacy and high remission rates. Maintenance data suggested a role of quetiapine as a good alternative to classical mood stabilizers in reducing recurrence rates of BD. A few studies on the efficacy in rapid cycling BD have also been published. Conclusions: Quetiapine is an effective agent for the short- and long-term treatment of BD. The mechanism of action of quetiapine as a mood stabilizer is still unknown. Some preliminary data suggest the involvement of glutamate pathways but further studies are needed to clarify this issue.",
keywords = "Atypical antipsychotics, Bipolar disorder, Quetiapine, Treatment",
author = "Emanuela Mundo and Elisabetta Cattaneo and Silvia Zanoni and Altamura, {A. Carlo}",
year = "2006",
doi = "10.2147/nedt.2006.2.2.139",
language = "English",
volume = "2",
pages = "139--148",
journal = "Neuropsychiatric Disease and Treatment",
issn = "1176-6328",
publisher = "Dove Medical Press Ltd.",
number = "2",

}

TY - JOUR

T1 - The use of atypical antipsychotics beyond psychoses

T2 - Efficacy of quetiapine in bipolar disorder

AU - Mundo, Emanuela

AU - Cattaneo, Elisabetta

AU - Zanoni, Silvia

AU - Altamura, A. Carlo

PY - 2006

Y1 - 2006

N2 - Background and rationale: Atypical antipsychotics have been successfully used in the treatment of bipolar disorder (BD), either as adjunctive or as monotherapy. Quetiapine is an atypical antipsychotic extensively used in the treatment of psychotic disorders. It has serotonergic and dopaminergic activity and it appears to be selective for the mesolimbic and mesocortical dopamine system. The aim of this paper was to review the recent literature on the use of quetiapine in the treatment of BD. Methods: The literature databases currently available online were searched for papers on quetiapine and BD. Papers and reports published between January 1995 and June 2005 were selected and reviewed critically. Results: Augmentative low dose quetiapine was found to be effective in BD partially responsive to conventional mood-stabilizers. Manic and mixed episodes have been the best studied, and quetiapine was found to be effective either as monotherapy or as adjunctive therapy in both randomized clinical trials and open-label studies. Data on the use of quetiapine in bipolar depression showed a significant efficacy and high remission rates. Maintenance data suggested a role of quetiapine as a good alternative to classical mood stabilizers in reducing recurrence rates of BD. A few studies on the efficacy in rapid cycling BD have also been published. Conclusions: Quetiapine is an effective agent for the short- and long-term treatment of BD. The mechanism of action of quetiapine as a mood stabilizer is still unknown. Some preliminary data suggest the involvement of glutamate pathways but further studies are needed to clarify this issue.

AB - Background and rationale: Atypical antipsychotics have been successfully used in the treatment of bipolar disorder (BD), either as adjunctive or as monotherapy. Quetiapine is an atypical antipsychotic extensively used in the treatment of psychotic disorders. It has serotonergic and dopaminergic activity and it appears to be selective for the mesolimbic and mesocortical dopamine system. The aim of this paper was to review the recent literature on the use of quetiapine in the treatment of BD. Methods: The literature databases currently available online were searched for papers on quetiapine and BD. Papers and reports published between January 1995 and June 2005 were selected and reviewed critically. Results: Augmentative low dose quetiapine was found to be effective in BD partially responsive to conventional mood-stabilizers. Manic and mixed episodes have been the best studied, and quetiapine was found to be effective either as monotherapy or as adjunctive therapy in both randomized clinical trials and open-label studies. Data on the use of quetiapine in bipolar depression showed a significant efficacy and high remission rates. Maintenance data suggested a role of quetiapine as a good alternative to classical mood stabilizers in reducing recurrence rates of BD. A few studies on the efficacy in rapid cycling BD have also been published. Conclusions: Quetiapine is an effective agent for the short- and long-term treatment of BD. The mechanism of action of quetiapine as a mood stabilizer is still unknown. Some preliminary data suggest the involvement of glutamate pathways but further studies are needed to clarify this issue.

KW - Atypical antipsychotics

KW - Bipolar disorder

KW - Quetiapine

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=33745929014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745929014&partnerID=8YFLogxK

U2 - 10.2147/nedt.2006.2.2.139

DO - 10.2147/nedt.2006.2.2.139

M3 - Article

VL - 2

SP - 139

EP - 148

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

SN - 1176-6328

IS - 2

ER -